Inhibition of the CD47-SIPRα interaction has been demonstrated to be an attractive strategy to increase the phagocytic activity of an anti-CD20 mAb, whereby phagocytosis was significantly increased by the co-injection of an anti-CD47 mAb, leading to complete tumour eradication24. Here, CD47 is linked to neoplasm.